tyrosine and tautomycin

tyrosine has been researched along with tautomycin in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Charlet-Berguerand, N; Elliott, DJ; Gattoni, R; Hagerman, PJ; Hukema, RK; Liu, Y; Rau, F; Richard, S; Schneider, A; Sellier, C; Tassone, F; Willemsen, R1
Chan, RJ; Gunawan, AM; Huang, SX; Liu, S; Luo, Y; Shen, B; Shen, W; Wang, L; Wu, L; Yang, Z; Yu, X; Yu, Z; Zhang, ZY1

Other Studies

2 other study(ies) available for tyrosine and tautomycin

ArticleYear
Sam68 sequestration and partial loss of function are associated with splicing alterations in FXTAS patients.
    The EMBO journal, 2010, Apr-07, Volume: 29, Issue:7

    Topics: Adaptor Proteins, Signal Transducing; Alternative Splicing; Animals; Ataxia; Cell Nucleus; Chlorocebus aethiops; COS Cells; DNA-Binding Proteins; Enzyme Inhibitors; Fragile X Syndrome; Heterogeneous-Nuclear Ribonucleoproteins; Humans; Mice; Phosphorylation; Pyrans; Repetitive Sequences, Nucleic Acid; RNA-Binding Proteins; RNA, Messenger; Spiro Compounds; Tyrosine

2010
SHP2 is a target of the immunosuppressant tautomycetin.
    Chemistry & biology, 2011, Jan-28, Volume: 18, Issue:1

    Topics: Amino Acid Sequence; Cell Differentiation; Cell Proliferation; Enzyme Activation; Enzyme Inhibitors; Furans; Hematopoietic Stem Cells; Humans; Immunosuppressive Agents; Jurkat Cells; Lipids; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Models, Molecular; Molecular Sequence Data; Monocytes; Phosphorylation; Protein Conformation; Protein Tyrosine Phosphatase, Non-Receptor Type 11; Pyrans; Signal Transduction; Spiro Compounds; Substrate Specificity; Tyrosine

2011